A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine
<p>Abstract</p> <p>Background</p> <p>Amodiaquine (AQ) along with sulphadoxine-pyrimethamine (SP) offers effective and cheaper treatment against chloroquine-resistant falciparum malaria in many parts of sub-Saharan Africa. Considering the previous history of hepatitis, a...
Main Authors: | Rath Srikanta, Singh Prabhat, Mishra Shrawan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/10/1/109 |
Similar Items
-
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal
by: Sow Diarietou, et al.
Published: (2009-06-01) -
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
by: Amin, A, et al.
Published: (2005) -
Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children
by: A Sowunmi, et al.
Published: (2006-12-01) -
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
by: East African Network for Monitoring Antimalarial Treatment (EANMAT)
Published: (2003) -
Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
by: Fanello, C, et al.
Published: (2006)